Invokamet 150mg/1000mg Tablets

Manufacturer JANSSEN Active Ingredient Canagliflozin and Metformin Tablets(kan a gli FLOE zin & met FOR min) Pronunciation IN-voh-KAH-met (can-a-GLI-floe-zin & met-FOR-min)
WARNING: Rarely, metformin may cause too much lactic acid in the blood (lactic acidosis). The risk is higher in people who have kidney problems, liver problems, heart failure, use alcohol, or take certain other drugs, including topiramate. The risk is also higher in people who are 65 or older and in people who are having surgery, an exam or test with contrast, or other procedures. If lactic acidosis happens, it can lead to other health problems and can be deadly. Kidney tests may be done while taking this drug.Do not take this drug if you have a very bad infection, low oxygen, or a lot of fluid loss (dehydration).Call your doctor right away if you have signs of too much lactic acid in the blood (lactic acidosis) like confusion; fast breathing; fast or slow heartbeat; a heartbeat that does not feel normal; very bad stomach pain, upset stomach, or throwing up; feeling very sleepy; shortness of breath; feeling very tired or weak; very bad dizziness; feeling cold; or muscle pain or cramps. @ COMMON USES: It is used to help control blood sugar in people with type 2 diabetes.It is used to lower the chance of heart attack, stroke, new or worse kidney problems, having to go to the hospital for heart failure, and death in some people.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Antidiabetic, SGLT2 Inhibitor and Biguanide Combination
🧬
Pharmacologic Class
Sodium-glucose co-transporter 2 (SGLT2) inhibitor; Biguanide
🤰
Pregnancy Category
Not available
FDA Approved
Aug 2014
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Invokamet is a medication that combines two different medicines, canagliflozin and metformin, to help lower blood sugar in adults with type 2 diabetes. Canagliflozin works by helping your kidneys remove more sugar from your body through your urine. Metformin works by reducing the amount of sugar your liver makes and helping your body use insulin better.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with meals as directed. It's also important to drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.

Storing and Disposing of Your Medication

Store your medication in its original container at room temperature, in a dry place, away from the bathroom. If you need to store your medication outside of its original container, discard any unused portion after 30 days.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take Invokamet exactly as prescribed by your doctor, usually once daily with your first meal.
  • Follow a healthy diet plan recommended by your doctor or a dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Stay well-hydrated, especially when exercising or in hot weather, to reduce the risk of dehydration.
  • Limit alcohol intake, as it can increase the risk of a serious side effect called lactic acidosis.
  • Monitor your blood sugar levels regularly as instructed by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Invokamet 150mg/1000mg once daily in the morning, taken with the first meal of the day. This is a common maintenance dose, not typically an initial dose.
Dose Range: 50 - 300 mg

Condition-Specific Dosing:

initialTherapy: Initial dose typically 50mg canagliflozin/500mg metformin or 50mg canagliflozin/1000mg metformin once daily. Titrate based on efficacy and tolerability.
maximumDose: Maximum recommended daily dose is 300mg canagliflozin and 2000mg metformin.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
⚕️

Dose Adjustments

Renal Impairment:

Mild: eGFR 60 to <90 mL/min/1.73m²: No dose adjustment needed. Continue to monitor renal function.
Moderate: eGFR 45 to <60 mL/min/1.73m²: Canagliflozin dose should not exceed 100mg daily. Metformin dose may need adjustment or discontinuation if eGFR falls below 45 mL/min/1.73m².
Severe: eGFR 30 to <45 mL/min/1.73m²: Canagliflozin is not recommended. Metformin is contraindicated.
Dialysis: eGFR <30 mL/min/1.73m² or End-Stage Renal Disease (ESRD) on dialysis: Contraindicated.
Note: Renal function should be assessed prior to initiation and periodically thereafter. Discontinue if eGFR falls persistently below 45 mL/min/1.73m².

Hepatic Impairment:

Mild: Canagliflozin: No dose adjustment needed. Metformin: No dose adjustment needed.
Moderate: Canagliflozin: No dose adjustment needed. Metformin: Use with caution; monitor for lactic acidosis.
Severe: Canagliflozin: No dose adjustment needed. Metformin: Contraindicated due to increased risk of lactic acidosis.
Note: Metformin accumulation and lactic acidosis risk are increased in severe hepatic impairment.

Pharmacology

🔬

Mechanism of Action

Invokamet combines two antihyperglycemic agents with different mechanisms of action: Canagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin, a biguanide. Canagliflozin lowers blood glucose by inhibiting SGLT2 in the renal proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion. Metformin primarily decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
📊

Pharmacokinetics

Absorption:

Bioavailability: Canagliflozin: Approximately 65%; Metformin: 50-60% (absolute oral bioavailability of a 500 mg metformin tablet given under fasting conditions).
Tmax: Canagliflozin: 1-2 hours; Metformin: 2-3 hours (immediate release).
FoodEffect: Canagliflozin: Food has no clinically meaningful effect on canagliflozin pharmacokinetics. Metformin: Food decreases the extent and slightly delays the absorption of metformin.

Distribution:

Vd: Canagliflozin: 83.4 L; Metformin: 654 ± 358 L.
ProteinBinding: Canagliflozin: Approximately 99%; Metformin: Negligible.
CnssPenetration: Canagliflozin: Limited; Metformin: Limited.

Elimination:

HalfLife: Canagliflozin: 10.6 hours (100mg) to 13.1 hours (300mg); Metformin: Plasma elimination half-life is approximately 6.2 hours, blood half-life is approximately 17.6 hours.
Clearance: Canagliflozin: Renal clearance is 1.30 L/h; Metformin: Renal clearance is approximately 3.5 times greater than creatinine clearance.
ExcretionRoute: Canagliflozin: Primarily fecal (approximately 41.5% as unchanged drug and metabolites), with renal excretion (approximately 33% as unchanged drug and metabolites); Metformin: Primarily renal (excreted unchanged in the urine).
Unchanged: Canagliflozin: Approximately 30% renally; Metformin: Approximately 90% renally.
⏱️

Pharmacodynamics

OnsetOfAction: Canagliflozin: Within hours; Metformin: Within days, full effect in 1-2 weeks.
PeakEffect: Canagliflozin: 4-6 hours; Metformin: 2-3 hours (IR).
DurationOfAction: Canagliflozin: 24 hours; Metformin: 12-24 hours (IR).

Safety & Warnings

⚠️

BLACK BOX WARNING

Postmarketing cases of lactic acidosis, a serious metabolic complication, have been reported with metformin use and can result in death. The risk of lactic acidosis is increased with renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors), age 65 years or greater, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, and hepatic impairment. If lactic acidosis is suspected, discontinue Invokamet and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Fluid and Electrolyte Problems: Mood changes, confusion, muscle pain or weakness, fast or abnormal heartbeat, severe dizziness or passing out, increased thirst, seizures, feeling very tired or weak, decreased appetite, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or severe upset stomach or vomiting.
Urinary Tract Infection (UTI): Blood in the urine, burning or pain when passing urine, feeling the need to pass urine often or right away, fever, lower stomach pain, or pelvic pain.
Kidney Problems: Unable to pass urine, change in how much urine is passed, blood in the urine, or a significant weight gain.
Vaginal Yeast Infection: Itching, bad odor, or discharge. Report these symptoms to your doctor.
Yeast Infection of the Penis: Pain, swelling, rash, or discharge. Report these symptoms to your doctor.
Bone Pain: Notify your doctor if you experience bone pain.
Low Blood Sugar: This medication may increase the risk of low blood sugar, especially when used with other diabetes medications. Signs of low blood sugar include dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, or sweating. If you experience any of these symptoms, contact your doctor right away and follow their instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Stomach Problems: While it's common to experience stomach upset, vomiting, or diarrhea when starting this medication, if you notice these symptoms later during treatment, contact your doctor immediately, as they may be a sign of a serious condition called lactic acidosis.
Rare but Serious Infection: A rare but potentially life-threatening infection has been reported with medications like this one. Seek medical help right away if you experience tenderness, redness, or swelling in the genital area, along with a fever or feeling unwell.
Increased Risk of Lower Limb Amputations: This medication may increase the risk of lower limb amputations, particularly toe and foot amputations. Discuss foot care with your doctor, and notify them if you have a history of amputation, blood vessel disease, nerve disease, or foot ulcers caused by diabetes. Contact your doctor immediately if you experience new pain or tenderness, sores or ulcers, or infections in your legs or feet.

Other Possible Side Effects

Most people taking this medication do not experience significant side effects, but some may occur. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Passing urine more often
Gas
Stomach pain or heartburn
Diarrhea, upset stomach, or vomiting
Headache
* Feeling tired or weak

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Signs of Lactic Acidosis (seek emergency care): unusual muscle pain, stomach discomfort, diarrhea, nausea, vomiting, feeling cold, dizziness, lightheadedness, or unusual tiredness/weakness.
  • Signs of Dehydration/Volume Depletion: dizziness, lightheadedness, feeling faint, especially when standing up.
  • Signs of Genital Yeast Infection (female): vaginal itching, discharge, or odor. (male): redness, itching, swelling of the penis, rash, or discharge.
  • Signs of Urinary Tract Infection (UTI): burning sensation when urinating, frequent urination, urgent need to urinate, pain in the lower abdomen or pelvis, fever.
  • Signs of Diabetic Ketoacidosis (DKA): nausea, vomiting, stomach pain, excessive thirst, frequent urination, unusual tiredness, trouble breathing, fruity-smelling breath.
  • Signs of Vitamin B12 Deficiency: unusual tiredness, weakness, numbness or tingling in hands or feet.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced.
Certain health conditions, such as:
+ Acidic blood problems
+ Kidney disease
+ Liver disease
+ Type 1 diabetes
Recent medical events, including:
+ A heart attack
+ A stroke
Any difficulties with eating or drinking, including situations where you may be required to fast before a procedure or surgery
Upcoming or recent exams or tests that involve contrast agents (within the past 48 hours)
Pregnancy or potential pregnancy. Note: This medication should not be taken during the second or third trimester of pregnancy.
* Breastfeeding. You should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine the safety of taking this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may need to stop this medication before certain surgeries, and they will advise you on when to resume taking it after the procedure.

Driving and Blood Sugar Levels

Do not drive if your blood sugar levels are low, as this can increase the risk of accidents. To minimize the risk of dizziness or fainting, get up slowly from sitting or lying down, and be cautious when climbing stairs.

Diet, Exercise, and Lab Tests

Follow the diet and exercise plan recommended by your doctor. If you are on a low-salt or salt-free diet, consult with your doctor. Regularly check your blood work and other lab tests as instructed by your doctor, and monitor your blood sugar levels as advised.

Interactions and Precautions

This medication may affect certain lab tests, so inform all your healthcare providers and lab workers that you are taking it. Discuss with your doctor before consuming alcohol. Be aware that this medication may cause high cholesterol, and consult your doctor if you have any concerns.

Dehydration and Heat

In hot weather or during physical activity, drink plenty of fluids to avoid dehydration. If you are unable to drink liquids or experience persistent stomach upset, vomiting, or diarrhea, contact your doctor to prevent dehydration, which can lead to low blood pressure or worsen kidney problems.

Blood Sugar Control

Stress, such as fever, infection, injury, or surgery, can make it more challenging to control blood sugar levels. Changes in physical activity, exercise, or diet can also impact blood sugar control.

Vitamin B-12 Levels and Ketoacidosis

Long-term treatment with metformin may lead to low vitamin B-12 levels. If you have a history of low vitamin B-12 levels, discuss this with your doctor. Additionally, this medication can cause ketoacidosis, a potentially life-threatening condition that requires hospital treatment. This risk is higher in people with diabetes, pancreas problems, or those who are sick, dehydrated, or have skipped meals. Check your ketone levels as instructed by your doctor.

Bone Health and Kidney Problems

This medication may increase the risk of broken bones. Discuss this with your doctor. Kidney problems and severe urinary tract infections (UTIs) have been reported, and in some cases, hospital treatment or dialysis may be necessary.

Age-Related Precautions

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Pregnancy and Birth Control

Women of childbearing age who have not been ovulating may be at risk of pregnancy while taking this medication. If you want to avoid pregnancy, use birth control. If you become pregnant or are planning to become pregnant, inform your doctor immediately, as this medication may harm the unborn baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypoglycemia (low blood sugar)
  • Lactic acidosis (severe muscle pain, stomach pain, vomiting, rapid breathing, dizziness, feeling cold)
  • Severe dehydration
  • Kidney failure

What to Do:

In case of overdose, contact a poison control center immediately (1-800-222-1222). Emergency medical attention may be required. Treatment is supportive and may include hemodialysis for metformin removal.

Drug Interactions

🚫

Contraindicated Interactions

  • Iodinated contrast agents (for Metformin, temporarily discontinue)
  • Severe renal impairment (eGFR <30 mL/min/1.73m²)
  • Metabolic acidosis, including diabetic ketoacidosis
🔴

Major Interactions

  • Diuretics (loop or thiazide): Increased risk of volume depletion and hypotension with canagliflozin.
  • UGT enzyme inducers (e.g., rifampin, phenytoin, phenobarbital, ritonavir): May decrease canagliflozin exposure and efficacy.
  • Digoxin: Canagliflozin may increase digoxin exposure.
  • Alcohol: Potentiates the effect of metformin on lactate metabolism, increasing the risk of lactic acidosis.
  • Carbonic anhydrase inhibitors (e.g., topiramate, zonisamide, acetazolamide, dichlorphenamide): May increase risk of lactic acidosis with metformin.
🟡

Moderate Interactions

  • Insulin and insulin secretagogues (e.g., sulfonylureas): Increased risk of hypoglycemia when co-administered with Invokamet; dose reduction of insulin/sulfonylurea may be required.
  • Cimetidine: May increase metformin plasma concentrations.
  • Other drugs eliminated by renal tubular secretion (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, vancomycin): May interact with metformin via competition for renal tubular transport systems.
🟢

Minor Interactions

  • Not specifically listed as minor for this combination, but general caution with drugs affecting glucose levels.

Monitoring

🔬

Baseline Monitoring

Renal function (eGFR)

Rationale: To determine appropriate dosing and identify contraindications for both canagliflozin and metformin.

Timing: Prior to initiation of therapy.

Glycated Hemoglobin (A1c)

Rationale: To establish baseline glycemic control.

Timing: Prior to initiation of therapy.

Vitamin B12 levels

Rationale: Metformin can cause vitamin B12 deficiency.

Timing: Consider baseline measurement, especially in patients with risk factors for B12 deficiency.

📊

Routine Monitoring

Renal function (eGFR)

Frequency: At least annually, or more frequently in patients at risk for renal impairment (e.g., elderly, those on diuretics).

Target: >45 mL/min/1.73m² for full dose; >30 mL/min/1.73m² for any use.

Action Threshold: Discontinue if eGFR falls persistently below 45 mL/min/1.73m²; contraindicated if <30 mL/min/1.73m².

Glycated Hemoglobin (A1c)

Frequency: Every 3-6 months.

Target: Individualized, typically <7% for most adults.

Action Threshold: If A1c remains above target, consider dose titration or addition of other agents.

Blood Glucose (Fasting and Postprandial)

Frequency: Regularly, as directed by healthcare provider.

Target: Individualized.

Action Threshold: Persistent hyperglycemia or hypoglycemia requires dose adjustment or re-evaluation of therapy.

Signs/Symptoms of Lactic Acidosis

Frequency: Continuously educate patient.

Target: N/A

Action Threshold: If suspected, discontinue Invokamet immediately and seek emergency medical attention.

Signs/Symptoms of Volume Depletion

Frequency: Regularly, especially in elderly or those on diuretics.

Target: N/A

Action Threshold: If symptomatic, assess volume status and consider temporary discontinuation or dose reduction.

Vitamin B12 levels

Frequency: Periodically, especially if anemia or neuropathy is suspected.

Target: Normal range.

Action Threshold: Supplement B12 if deficiency is confirmed.

👁️

Symptom Monitoring

  • Unusual muscle pain
  • Stomach discomfort
  • Diarrhea
  • Nausea
  • Vomiting
  • Weakness
  • Dizziness
  • Lightheadedness
  • Increased thirst
  • Increased urination
  • Genital itching or discharge
  • Painful urination
  • Fever
  • Swelling in legs or feet
  • Unusual fatigue
  • Shortness of breath

Special Patient Groups

🤰

Pregnancy

Invokamet is not recommended during the second and third trimesters of pregnancy due to potential adverse effects on renal development in the fetus. Limited data on use in pregnant women are insufficient to determine drug-associated risks for major birth defects or miscarriage. Metformin is generally considered safer than canagliflozin during pregnancy if medication is needed for glycemic control.

Trimester-Specific Risks:

First Trimester: Canagliflozin: Limited human data, animal studies show adverse renal effects at high doses. Metformin: Generally considered low risk, often continued if benefits outweigh risks.
Second Trimester: Canagliflozin: Not recommended due to potential for adverse renal development in the fetus. Metformin: Generally considered low risk.
Third Trimester: Canagliflozin: Not recommended due to potential for adverse renal development in the fetus. Metformin: Generally considered low risk.
🤱

Lactation

Canagliflozin is present in breast milk in animal studies, and there is a potential for serious adverse reactions in a breastfed infant (e.g., renal dysfunction, hypoglycemia). Metformin is excreted into human milk in small amounts, and adverse effects in breastfed infants are not expected. Due to the canagliflozin component, breastfeeding is not recommended while taking Invokamet.

Infant Risk: Canagliflozin: Moderate to High risk (potential for renal dysfunction, hypoglycemia, and other SGLT2 inhibitor-related effects). Metformin: Low risk.
👶

Pediatric Use

Safety and effectiveness of Invokamet have not been established in pediatric patients. Not recommended for use in patients younger than 18 years of age.

👴

Geriatric Use

Elderly patients (≥65 years of age) are more likely to have decreased renal function and may be at increased risk for volume depletion, hypotension, and lactic acidosis (due to metformin). Renal function should be assessed more frequently. Canagliflozin dose may need to be limited to 100mg daily if eGFR is 45 to <60 mL/min/1.73m². Exercise caution with dose titration.

Clinical Information

💎

Clinical Pearls

  • Always take Invokamet with the first meal of the day to minimize gastrointestinal side effects of metformin.
  • Ensure adequate hydration, especially during illness, hot weather, or strenuous exercise, to reduce the risk of volume depletion and acute kidney injury.
  • Educate patients on the signs and symptoms of lactic acidosis (for metformin) and diabetic ketoacidosis (for canagliflozin), emphasizing the need for immediate medical attention if these occur.
  • Temporarily discontinue Invokamet before any radiological procedure involving iodinated contrast agents or any surgical procedure requiring restricted food and fluid intake.
  • Monitor for genital mycotic infections and urinary tract infections, which are common side effects of SGLT2 inhibitors.
  • Consider periodic monitoring of Vitamin B12 levels in patients on long-term metformin therapy, especially if anemia or neuropathy develops.
🔄

Alternative Therapies

  • Other SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin, ertugliflozin)
  • Other biguanides (Metformin monotherapy)
  • DPP-4 inhibitors (e.g., sitagliptin, saxagliptin, linagliptin)
  • GLP-1 receptor agonists (e.g., liraglutide, semaglutide, dulaglutide)
  • Sulfonylureas (e.g., glipizide, glyburide, glimepiride)
  • Thiazolidinediones (e.g., pioglitazone, rosiglitazone)
  • Insulin
💰

Cost & Coverage

Average Cost: $500 - $700 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Preferred or Non-Preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide details about the medication taken, the quantity, and the time it occurred.